Vertex Pharmaceuticals Inc (VRTX)

NASDAQ

$480.50

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

Sector:

Industry:

68 analysts

Buy

Target: $554.43 (+15.39%)

Market Cap

$121B

Profit Margin

34.5%

Forward P/E

25.45

P/E Ratio

27.99

Adjust inflation

Log

Valuation

Market Cap$121B

P/E27.99

Forward P/E25.45

PEG1.72

P/S9.89

P/B6.30

Profitability

Total Revenue (TTM)$12B

Gross Profit (TTM)$6.65B

EBITDA$4.90B

Profit Margin34.5%

Operating Margin38.1%

EPS$17.04

Financial Health

Free Cash Flow Yield3.06%

Growth & Risk

EPS 5Y CAGR+9.89%

Revenue 5Y CAGR+13.75%

FCF 5Y CAGR+4.01%

Beta (5Y)0.49

Sharpe Ratio0.18